Poly Medicure shareholders approve all resolutions at 31st AGM
- All five resolutions at Poly Medicure's 31st AGM were approved by shareholders
- Total shareholder base stood at 76,353 as of the record date
- Financial statements for FY26 and dividend declaration were unanimously supported
- Directors Rishi Baid and Devendra Raj Mehta were reappointed by rotation
*this image is generated using AI for illustrative purposes only.
Poly Medicure Limited shareholders approved all five resolutions at its 31st Annual General Meeting (AGM) held on September 5, 2026. The company conducted the meeting via video conference and other audio-visual means in compliance with the Companies Act, 2013.
The Board of Directors appointed Pawan Kumar Mishra, a practicing Company Secretary, as the scrutinizer for the remote e-voting and e-voting processes. Shareholders voted between September 2 and September 4, 2026, for remote e-voting, with additional voting available during the AGM.
Voting Participation
As of the record date, the company had 76,353 equity shareholders. A total of 91 shareholders attended the meeting through video conferencing. This included four promoters and promoter group members and 87 public shareholders.
Resolutions Approved
Shareholders approved the following agenda items:
- Adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026.
- Declaration of dividend on equity shares for FY26.
- Reappointment of Rishi Baid as a director retiring by rotation.
- Reappointment of Devendra Raj Mehta as a non-executive non-independent director, having attained the age of 75 years.
- Approval of remuneration for M/s Jai Prakash & Company, Cost Accountants, as the cost auditor for FY27.
Voting Results Overview
The table below summarizes the voting outcomes for key resolutions:
| Resolution | Votes In Favour | Votes Against | Outcome |
|---|---|---|---|
| Financial Statements (FY26) | 87,039,468 | 53 | Passed |
| Dividend Declaration | 87,039,541 | 1,548 | Passed |
| Reappointment: Rishi Baid | 73,948,970 | 594,195 | Passed |
| Reappointment: Devendra Raj Mehta | 86,237,962 | 801,559 | Passed |
| Cost Auditor Remuneration | 87,039,427 | 94 | Passed |
All ordinary resolutions received requisite majority support. The special resolution regarding the reappointment of Devendra Raj Mehta also passed with the required special majority under Section 114(2) of the Companies Act, 2013.
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.08% | -1.84% | -1.36% | +21.65% | -16.33% | 0.0% |
How might the declared dividend for FY26 influence Poly Medicure's valuation multiples and investor sentiment in the near term?
What strategic initiatives is Poly Medicure expected to prioritize following the reappointment of Rishi Baid and Devendra Raj Mehta to the Board?
Given the low number of physical attendees relative to total shareholders, does the high remote e-voting participation indicate a shift in shareholder engagement trends for the company?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
